Subtype-Specific Detection in Stage Ia Breast Cancer: Integrating Raman Spectroscopy, Machine Learning, and Liquid Biopsy for Personalised Diagnostics.

Journal: Journal of biophotonics
PMID:

Abstract

This study explores the integration of Raman spectroscopy (RS) with machine learning for the early detection and subtyping of breast cancer using blood plasma samples. We performed detailed spectral analyses, identifying significant spectral patterns associated with cancer biomarkers. Our findings demonstrate the potential for classifying the four major subtypes of breast cancer at stage Ia with an average sensitivity and specificity of 90% and 95%, respectively, and a cross-validated macro-averaged area under the curve (AUC) of 0.98. This research highlights efforts to integrate vibrational spectroscopy with machine learning, enhancing cancer diagnostics through a non-invasive, personalised approach for early detection and monitoring disease progression. This study is the first of its kind to utilise RS and machine learning to classify the four major breast cancer subtypes at stage Ia.

Authors

  • Kevin Saruni Tipatet
    Institute for BioEngineering, School of Engineering, University of Edinburgh, Edinburgh, UK.
  • Katie Hanna
    Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • Liam Davison-Gates
    Institute for BioEngineering, School of Engineering, University of Edinburgh, Edinburgh, UK.
  • Mario Kerst
    Faculty of Life Sciences, Rhine-Waal University of Applied Sciences, Kleve, Germany.
  • Andrew Downes
    Institute for BioEngineering, School of Engineering, University of Edinburgh, Edinburgh, UK.